Wealthspire Advisors (New York)’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
CAM
Wealthspire Advisors (New York)'s LMAT Position: Q4 2025 in Review
Wealthspire Advisors (New York) sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 29 shares — an estimated $2.54K sold.
Wealthspire Advisors (New York) first reported a position in LMAT in Q3 2025 and held it in 1 quarter. The position peaked at $2.54K in Q3 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.
- Wealthspire Advisors (New York) reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
- Wealthspire Advisors (New York) sold 29 LeMaitre Vascular shares in Q4 2025, an estimated $2.54K.
- Wealthspire Advisors (New York) first reported a position in LeMaitre Vascular in Q3 2025 and held it in 1 quarter.
- Wealthspire Advisors (New York)'s LeMaitre Vascular position peaked at $2.54K in Q3 2025.
- 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.
Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.